183FILMPHARMA LTD

🌿Early-stageactive
15375931 · ltd · incorporated 2023-12-29
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Dec 2024
Net worth
£3.0k
book net assets
Opportunity
69/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Dispensing chemist in specialised stores
Sector: Wholesale & retail
ALSO REGISTERED FOR
  • 90030Artistic creation
Investor take
Pursue
Asset-holding vehicle. Reasonable fundamentals — worth a memo before deciding.

Opportunity 69/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Deleverage or restructure. Leverage at 100% of assets — consider sale of non-core assets or equity injection. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: medium (71/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 2 SIC codes, incorporation date
100
Financials
1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed
50
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
1 connected companies via shared directors
48
Filing history
9 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
69/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
82
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £2,990
High leverage
Liabilities are 100% of total assets
Leverage
100%
Liabilities / Total assets

Key financials

1 year extracted from filed iXBRL accounts
Cash
Net Worth
£3k
Current Assets
£4k
Current Liabilities

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2024-12-31
Total assets£5.2k
Current assets£4.0k
Net assets£3.0k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
5
filings
  • 2 address
  • 1 officers
  • 1 persons-with-significant-control
Last 180 days
7
filings
  • 2 address
  • 2 persons-with-significant-control
  • 1 officers
Counts from Companies House filing history.
Corporate timeline (9 events)Click to expand
  1. 2026-03-01
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  2. 2026-02-09
    📄
    change-person-director-company-with-change-date
    officers · CH01
  3. 2026-02-09
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  4. 2026-02-09
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  5. 2026-01-28
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  6. 2025-11-13
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  7. 2023-12-29
    🏢
    Company incorporated
    As 183FILMPHARMA LTD
  8. 2023-12-29
    ALABI, Precious Olumoroti Olufunke appointed
    director
  9. 2023-12-29
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

80/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Young company: Only 2.3 years old — management layer unlikely to be developed.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

1 low
Multiple registered office changes
low

Multiple address changes in a short period can indicate operational instability or admin disorder.

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Ms Precious Olumoroti Olufunke Alabi
Individual · British · DOB 03/1995 · age 31
75100%
75–100%board control75-100% shares · 75-100% voting · board control29/12/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Retail · M postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
10 PIXELS MCR LIMITED
16547963 · est 2025 · no financials extracted
12 STARS LTD
15705187 · est 2024 · no financials extracted
1y
1205 LIMITED
15554600 · est 2024 · no financials extracted
2y
127STAMFORD LIMITED
14702421 · est 2023 · no financials extracted
3y
16335699 LTD
16335699 · est 2025 · no financials extracted
1y
18 GREENBROOK LIMITED
15986992 · est 2024 · no financials extracted
1y
1ONBUY LTD
16698925 · est 2025 · no financials extracted
1ST BUSINESS LTD
11555422 · est 2018 · no financials extracted
7y
1ST CHOICE FRUITS LTD
11048258 · est 2017 · no financials extracted
8y
1STPURE LTD
11595062 · est 2018 · no financials extracted
7y
20K AND A DEAD SHEEP LTD
13155816 · est 2021 · no financials extracted
5y
23 EMPORIUM LIMITED
15301921 · est 2023 · no financials extracted
2y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

9 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-12-29
Jurisdictionengland-wales
Primary SIC47730 — Dispensing chemist in specialised stores

Registered office

Bartle House
Oxford Court
Manchester
M2 3WQ
England

Filing status

Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2027-01-11
Last: 2025-12-28

Officers (1 active · 0 resigned)

ALABI, Precious Olumoroti Olufunke
director · ~31y · appointed 2023-12-29
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (9 total)

change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2026-03-01
change-person-director-company-with-change-date
officers · CH01
2026-02-09
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-02-09
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2026-02-09
confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-02-05
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-01-28
accounts-with-accounts-type-micro-entity
accounts · AA
2025-11-13
confirmation-statement-with-updates
confirmation-statement · CS01
2025-01-01
incorporation-company
incorporation · NEWINC
2023-12-29